Both management and prognosis vary with the many different varieties of non
-Hodgkin's lymphoma, In large-cell disease, age and other risk factors infl
uence prognosis. Relapses may respond to chemotherapy plus autologous bone
marrow transplantation. Therapy with antibodies to tumor cells has made its
debut, but its role remains unclear.